Overall Status

Recruiting (4)

Active, not recruiting (2)

Not yet recruiting (1)

Unknown status (1)

Withdrawn (1)

Phase

early phase 1 (2)

phase 1 (2)

phase 1/phase 2 (2)

phase 2 (2)

phase 3 (1)

Sponsor

M.D. Anderson Cancer Center (3)

National Cancer Institute (NCI) (2)

Alliance for Clinical Trials in Oncology (1)

Mayo Clinic (1)

Roswell Park Cancer Institute (1)

University of Southern California (1)

Collaborator

National Cancer Institute (NCI) (5)

Ipsen (1)

United States Department of Defense (1)

Study Documents

Intervention Type

biological (8)

drug (8)

other (3)

procedure (3)

radiation (1)

Funder Type

Other (7)

NIH (2)

Study Type

Interventional (9)

unresectable gastroesophageal junction adenocarcinoma

Showing 1 - 9 of 9

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

Recruiting

Clinical Stage II Esophageal Adenocarcinoma AJCC v8
+10 more

Biopsy
+8 more

Buffalo, New York

Roswell Park Cancer Institute

Jan 20, 2023

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

Not yet recruiting

Advanced Esophageal Adenocarcinoma
+14 more

Fluorouracil
+8 more

(no location specified)

Jan 3, 2023

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Active, not recruiting

Clinical Stage III Gastric Cancer AJCC v8
+7 more

Berzosertib
+4 more

Duarte, California
+30 more

Jan 7, 2023

Metastatic Esophageal Carcinoma, Metastatic Gastric Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in

Active, not recruiting

Metastatic Esophageal Carcinoma
+12 more

Olaparib
Ramucirumab

Corona, California
+31 more

Aug 9, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting

Anatomic Stage III Breast Cancer AJCC v8
+129 more

Cyclophosphamide
+3 more

Jacksonville, Florida

Mayo Clinic in Florida

Apr 8, 2022

Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8

Recruiting

Advanced Gastric Adenocarcinoma
+32 more

Lenvatinib
Pembrolizumab

Houston, Texas

M D Anderson Cancer Center

Mar 2, 2022

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma

Recruiting

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
+18 more

Docetaxel
+4 more

Houston, Texas

M D Anderson Cancer Center

Oct 16, 2020

Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

Unknown status

Advanced Gastroesophageal Junction Adenocarcinoma
+24 more

Pembrolizumab

Houston, Texas

M D Anderson Cancer Center

Jun 18, 2020

Locally Advanced Unresectable Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Metastatic

Withdrawn

Locally Advanced Unresectable Gastric Adenocarcinoma
+5 more

Liposomal Irinotecan
+3 more

Los Angeles, California

USC / Norris Comprehensive Cancer Center

Mar 25, 2020